These gene expression results suggesting greater immune infiltration in KRAS-indep and KRAS-low tumors were corroborated by analysis of T-cell infiltration based on TCGA digital-pathology examination of the tumor tissue slides (Fig. 4d)40. This evidence concerns the gene KRAS and neoplasm.